Updated Jul 16, 2026
Walbert Timothy P has filed 5 SEC Form 4 filings across 4 companies in the last 90 days.
Timothy P. Walbert is a seasoned executive in the biotechnology sector, currently serving as a director at BioMarin Pharmaceutical Inc. He has extensive experience in the development and commercialization of therapies for rare genetic diseases.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | KARD | Kardigan, Inc. | A — Grant or award | 20.7K | $0.00 | |
| 2026-06-04 | BMRN | BIOMARIN PHARMACEUTICAL INC | A — Grant or award | 7.5K | $0.00 | |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 4.0K | — | |
| 2025-05-20 | BMRN | BIOMARIN PHARMACEUTICAL INC | A — Grant or award | 6.7K | $0.00 |
Timothy P. Walbert is a seasoned executive in the biotechnology sector, currently serving as a director at BioMarin Pharmaceutical Inc. He has extensive experience in the development and commercialization of therapies for rare genetic diseases.…
5 primary Form 4 filings in the last 90 days, covering 4 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Walbert Timothy P profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.